Now that 2021 is here, you’re not alone in trying to possibly lose weight. In fact, an estimated 45 million Americans go on some sort of diet each year. But are you sabotaging yourself even before you get started? As you think about your health goals in this new year, be sure you’re not falling into the trap of these habits, which may seem harmless but are actually culprits when looking at the scale going up.

Although initial animal studies indicated this drug might increase the risk of cancer, current research is showing the opposite. In a large systematic review and meta-analysis, for example, researchers showed that patients who took these drugs before their cancer diagnosis had a 21% lower risk of all-cause mortality and a 31% lower risk of cancer-specific mortality. What is it?

2020 was brutal for healthcare workers, no question. Based on more than 1,250 responses from a survey sent out about how the pandemic has affected them both personally and professionally, MDLinx learned that roughly half of healthcare workers are seriously rethinking their careers or practice. Half! So then what is the outlook for 2021? Does oncology have a bright future?

According to several polls (though some said they might change their minds for various reasons), around 4 in 10 Americans have said they will not get a coronavirus vaccine. When it comes to the safety of these vaccines, however, there are good reasons to be confident already. Here are nine explanations to give to a patient, friend, or family member that may be skeptical of the shots.

Investing earlier during your financial trajectory is a good idea: The earlier investments are made, the greater the time value of money. If you are interested in accumulating wealth, it is best to start early and pick some winning strategies. From our friends at MDLinx, here are 10 money moves to consider earlier rather than later.

In June 2020, the US Food and Drug Administration (FDA) granted accelerated approval to tazemetostat (Tazverik, Epizyme), an oral EZH2 inhibitor for the treatment of adult patients with relapsed/refractory follicular lymphoma (FL). Clinical Advances in Hematology & Oncology takes a closer look at this new treatment through a conversation with Dr. Connie Lee Batlevi from MSKCC.